(Q43861062)

English

P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection (English)

1 reference

Europe PubMed Central

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

27 November 2017

object named as

Chih-Hung Hsu

6

0 references

object named as

Kuo-Chin Huang

2

0 references

object named as

Kun-Huei Yeh

7

0 references

object named as

Ann-Lii Cheng

5

0 references

author name string

Yung-Ming Cheng

3

1 reference

Europe PubMed Central

27 November 2017

Hey-Chi Hsu

4

1 reference

Europe PubMed Central

27 November 2017

Shih-Ming Wang

8

1 reference

Europe PubMed Central

27 November 2017

King-Jen Chang

9

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

27 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

27 November 2017

97

1 reference

Europe PubMed Central

27 November 2017

451-457

1 reference

Europe PubMed Central

27 November 2017

4

1 reference

Europe PubMed Central

27 November 2017

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Cancer cell cycles

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Clinical implications of p53 mutations

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

The clinical significance of p53 aberrations in human tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

P53 in tumour pathology: can we trust immunocytochemistry?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Introduction: p53--the first twenty years

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Residual tumor (R) classification and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic factor research in oncology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Issues in surgical randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Molecular Markers of Prognosis in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Cancer therapy and p53.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

The results of colorectal cancer treatment by p53 status: treatment-specific overview

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Comparative Survival Analysis of p53 Gene Mutations and Protein Accumulation in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Impact of surgeon's technique on outcome after treatment of rectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

How to improve the present TNM staging system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Association of p53 mutations with short survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic value of p53 genetic changes in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Prognostic markers for colorectal cancer: expression of P53 and BCL2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Response rates, survival, and chemotherapy trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Genetic prognostic markers for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Can we predict response to 5-FU?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1637

21 January 2018

Identifiers

10.1002/IJC.1637

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43861062&oldid=2103970336"